New Ray Medicine International Holding Ltd., a company incorporated in Bermuda, has announced a proposed capital reorganisation. This restructuring will involve a share consolidation, capital reduction, and share sub-division, consolidating every ten issued and unissued existing shares of par value HK$0.05 into one consolidated share of par value HK$0.50. Subsequently, each authorised but unissued consolidated share will be subdivided into fifty new shares of par value HK$0.01 each. The move aims to address market price extremities in accordance with Hong Kong Stock Exchange rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.